An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonas aeruginosa
Microbial Pathogenesis · 2025-07 · 204 · 107560
DOI: 10.1016/j.micpath.2025.107560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025-07. Verfasst von Emel Mataracı-Kara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Microbiology, Faculty of Pharmacy University, 34116, Beyazit-Istanbul, Turkey. Electronic address: emataraci@istanbul.ed…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Pseudomonas aeruginosa, Cephalosporins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Istanbul Üniversitesi, Istanbul University Scientific Research Projects Unit.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy University, 34116, Beyazit-Istanbul, Turkey. Electronic address: emataraci@istanbul.edu.tr.
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy University, 34116, Beyazit-Istanbul, Turkey. Electronic address: bekirozer@istanbul.edu.tr.
- Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medipol University, 34214, Istanbul, Turkey. Electronic address: myilmaz@medipol.edu.tr.
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy University, 34116, Beyazit-Istanbul, Turkey. Electronic address: berna.ozbek@istanbul.edu.tr.
Förderung
- Istanbul Üniversitesi
- Istanbul University Scientific Research Projects Unit
Zitieren
APA
Mataracı-Kara, E., Özer, B., Yilmaz, M., & Özbek-Çelik, B. (2025). An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonas aeruginosa. Microbial Pathogenesis, 204, 107560. https://doi.org/10.1016/j.micpath.2025.107560
Vancouver
Mataracı-Kara E, Özer B, Yilmaz M, Özbek-Çelik B. An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonas aeruginosa. Microbial Pathogenesis. 2025;204:107560. doi:10.1016/j.micpath.2025.107560
BibTeX
@article{MataracKara2025,
author = {Mataracı-Kara, Emel and Özer, Bekir and Yilmaz, Mesut and Özbek-Çelik, Berna},
title = {An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonas aeruginosa},
journal = {Microbial Pathogenesis},
year = {2025},
volume = {204},
pages = {107560},
doi = {10.1016/j.micpath.2025.107560}
}
EUVIMED